8.3 Occupational Health & Recreational Safety Counseling

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

8.3 Occupational Health & Recreational Safety Counseling

Key Takeaways Explain This Topic AI

The WHAM occupational history framework systematically identifies workplace etiologies: What do you do, How do you do it, Are symptoms worse at work and better on days off, and are Many coworkers sick?

Occupational pneumoconioses exhibit distinct radiological and clinical patterns: Silicosis (sandblasting, stone masonry) causes upper lobe nodular opacities with eggshell hilar calcification and confers a 3- to 30-fold increased risk of tuberculosis (requiring screening with a ≥5 mm TST cutoff); Asbestosis (shipyards, construction) causes lower lobe basilar fibrosis, calcified diaphragmatic pleural plaques, and multiplies the risk of bronchogenic carcinoma (multiplicative synergy with smoking) and malignant mesothelioma (independent of smoking).

Occupational asthma is confirmed by serial peak expiratory flow rate (PEFR) monitoring demonstrating ≥20% diurnal variability or drop during work shifts compared to days off; prompt, complete cessation of exposure is the only curative intervention.

Percutaneous occupational bloodborne pathogen exposure to HIV requires rapid post-exposure prophylaxis (PEP) within 72 hours (ideally within 2 hours) using a 3-drug 28-day antiretroviral regimen; non-immune healthcare workers exposed to HBV require both Hepatitis B Immune Globulin (HBIG) and the hepatitis B vaccine series within 24 hours.

Primary care recreational safety counseling must advocate CPSC-certified bicycle helmets (reducing head and traumatic brain injury by 60–85%), 4-sided pool isolation fencing with self-closing/self-latching gates for drowning prevention, broad-spectrum SPF ≥30 sunscreen, and acclimatization with scheduled hydration (8 oz every 15–20 minutes) for heat illness prevention.

Last updated: September 2026

The Primary Care Occupational Health History (WHAM Framework)

Occupational exposures contribute substantially to chronic disease morbidity in the adult population, accounting for an estimated 15% to 20% of adult asthma and chronic obstructive pulmonary disease (COPD) cases, significant portions of interstitial lung disease, upper extremity musculoskeletal disorders, and acute toxicities. Despite this prevalence, occupational histories are documented in fewer than 20% of routine outpatient encounters.

The WHAM Framework

The WHAM framework provides a standardized, efficient method for uncovering workplace contributors to clinical illness: +-----------------------------------------------------------------------------------------+

| THE WHAM FRAMEWORK |
| |
| W - WHAT do you do? |
| Current job title, specific tasks, past employment, military service |
| |
| H - HOW do you do it? |
| Physical demands, chemical exposures, dusts, fumes, biological agents, |
| ventilation, Personal Protective Equipment (PPE) use and fit-testing |
| |
| A - Are symptoms worse AT WORK? |
| Temporal association: worsening during shifts, improvement on weekends, |
| holidays, or prolonged medical leave |
| |
| M - Are MANY coworkers sick? |
| Coworkers experiencing similar symptoms; shared environmental toxins or |
| poorly ventilated buildings |
+-----------------------------------------------------------------------------------------+
Occupational Safety and Health Administration (OSHA) & Safety Data Sheets (SDS)

Safety Data Sheets (SDS) : Standardized 16-section documents mandated by OSHA under the Hazard Communication Standard. They provide comprehensive data on chemical properties, toxicity, permissible exposure limits (PEL), personal protection requirements, and first-aid measures. Clinicians should instruct patients with suspected chemical exposures to obtain the SDS from their employer's hazard communications officer.

OSHA Form 300 : The mandatory employer log of work-related injuries and illnesses, useful in evaluating documented clusters of occupational disease.

Occupational Pulmonary Diseases: The Pneumoconioses

Pneumoconioses are chronic, non-neoplastic inflammatory and fibrotic lung diseases caused by the inhalation and tissue retention of inorganic mineral dusts.

Master Comparison: Occupational Pneumoconioses

Disease Entity Typical Occupational Exposures Characteristic Radiographic Findings Histopathology & Pathognomonic Features High-Yield Clinical Pearls & Complications

Silicosis Sandblasting, granite cutting, masonry, foundry work, pottery, quartz quarrying, hydraulic fracturing Upper lobe predominance; small rounded nodular opacities (<10 mm); eggshell calcification of hilar and mediastinal lymph nodes Whorled concentric hyaline collagenous nodules; birefringent crystalline silica particles under polarized light Silicotuberculosis : 3- to 30-fold increased risk of M. tuberculosis ; mandatory baseline and annual screening with TST cutoff ≥5 mm ; progressive massive fibrosis (PMF)

Asbestosis Shipyard workers, pipefitters, insulation installers, boiler workers, building demolition, automobile brake lining mechanics Lower lobe / basilar predominance; reticulonodular interstitial opacities; pleural plaques (calcified diaphragmatic and posterolateral pleura) Asbestos bodies (ferruginous bodies) : golden-brown dumbbell-shaped fibers coated with iron-protein; Prussian blue stain positive Bronchogenic carcinoma is the most common cancer (multiplicative synergy with smoking: up to 90-fold risk); Malignant Mesothelioma (30–50y latency; smoking does NOT increase mesothelioma risk )

Coal Workers' Pneumoconiosis (CWP) Underground coal miners, carbon electrode workers Upper lobe macules and nodular opacities; can coalesce into large fibrotic masses Coal macules: aggregates of coal dust surrounding respiratory bronchioles with focal emphysema Caplan Syndrome : Co-occurrence of rheumatoid arthritis with rheumatoid pneumoconiotic nodules; progressive massive fibrosis (black lung)

Berylliosis Aerospace manufacturing, nuclear industry, electronics, telecommunications, dental alloys, ceramics Upper lobe interstitial infiltrates, hilar lymphadenopathy; mimics sarcoidosis Non-caseating granulomas on lung biopsy; T-cell mediated type IV hypersensitivity Confirmed by Beryllium Lymphocyte Proliferation Test (BeLPT) in blood or BAL; responds to systemic corticosteroids

Byssinosis ("Brown Lung") Textile industry (cotton, flax, hemp processing) Often normal chest radiograph; hyperinflation Non-fibrotic; airway reactivity mediated by bacterial endotoxins in cotton bract "Monday Chest Tightness" : Dyspnea and wheezing worse on the first day back after the weekend, improving later in the work week

Silicosis and the Silicotuberculosis Mandate

Pathogenesis : Free crystalline silica (silicon dioxide) particles (0.5 to 5 µm) are engulfed by alveolar macrophages. Silica destroys phagolysosomal membranes, triggering macrophage lysis and the release of inflammatory cytokines (IL-1, TNF-alpha), promoting persistent fibrogenesis.

The Tuberculosis Association : Macrophage destruction impairs cell-mediated defenses against mycobacterial pathogens. Patients with silicosis have a 3- to 30-fold increased risk of developing active pulmonary tuberculosis (silicotuberculosis).

Mandatory Screening Protocol : All patients with silicosis must receive baseline screening for latent tuberculosis infection (LTBI) via interferon-gamma release assay (IGRA) or tuberculin skin test (TST). In silicosis patients, a TST induration of ≥5 mm is considered positive (analogous to HIV-infected or immunocompromised individuals), and positive individuals must receive preventive LTBI treatment (e.g., 4 months of daily rifampin or 3 months of once-weekly isoniazid plus rifapentine).

Asbestosis and Neoplastic Synergy

Pleural Plaques : The most common radiographic manifestation of asbestos exposure. Characterized by well-circumscribed, bilateral, dense fibrotic and calcified plaques localized to the parietal pleura, predominantly along the dome of the diaphragm and posterolateral rib cage . Pleural plaques themselves are benign markers of exposure ; they do not cause functional pulmonary impairment and do not undergo malignant transformation.

Bronchogenic Carcinoma vs. Mesothelioma :

Bronchogenic Carcinoma : By far the most frequent malignancy caused by asbestos exposure. Asbestos exposure and cigarette smoking exhibit an extraordinary supra-additive, multiplicative synergy (baseline risk = 1x; asbestos alone = 5x; smoking alone = 10x; combined asbestos + smoking = 50- to 90-fold increased risk ).

Malignant Mesothelioma : A highly aggressive, lethal malignancy of the pleural or peritoneal mesothelium. Characterized by an extensive latency period of 30 to 50 years between initial exposure and clinical onset. Crucially, cigarette smoking does NOT increase the risk of malignant mesothelioma .

Occupational Asthma and Work-Exacerbated Asthma

Work-related asthma encompasses two distinct pathophysiologic entities:

Occupational Asthma : De novo asthma caused specifically by conditions, substances, or exposures in the work environment.

Sensitizer-Induced (Immunologic; 90%) : Latency period between initial exposure and sensitization (IgE-mediated or cell-mediated). Common agents include diisocyanates (spray painters, polyurethane foam manufacturing), flour and grain dust (bakers), western red cedar / plicatic acid (sawmill workers, carpenters), laboratory animal proteins (research technicians), and glutaraldehyde (healthcare workers).

Irritant-Induced (Non-Immunologic; 10%) : Rapid onset without latency following high-level toxic irritant gas, vapor, or fume exposure (e.g., chlorine gas, ammonia); known as Reactive Airways Dysfunction Syndrome (RADS) .

Work-Exacerbated Asthma : Pre-existing or concurrent asthma worsened by non-specific physical or chemical triggers in the workplace (e.g., cold air, physical exertion, dust, stress).

Diagnostic Protocol: Serial Peak Expiratory Flow Rate (PEFR)

Gold Standard Primary Care Evaluation : Serial Peak Expiratory Flow Rate (PEFR) monitoring performed at least 4 times daily (upon waking, mid-shift, end-of-shift, and bedtime) for 2 weeks at work and 2 consecutive weeks away from work (vacation or leave).

Diagnostic Criteria : A documented ≥20% diurnal variability or a significant, reproducible drop in PEFR during work periods that normalizes during periods away from work confirms work-related bronchoconstriction.

Management : The single most effective, disease-modifying intervention for sensitizer-induced occupational asthma is prompt, permanent, and complete removal from the offending workplace exposure . Continued low-level exposure leads to irreversible airway remodeling and chronic, permanent obstructive airway disease.

Workplace Ergonomics and Repetitive Strain Injuries

Musculoskeletal disorders account for over 30% of all lost-workday occupational injuries in the United States, driven by repetitive motions, sustained awkward postures, vibration, and forceful exertion.

Upper Extremity Entrapment Neuropathies & Tendinopathies

Carpal Tunnel Syndrome (CTS) :

Mechanism : Repetitive wrist flexion/extension, keyboarding, or hand-arm vibration leading to increased pressure within the carpal tunnel and compression of the median nerve beneath the transverse carpal ligament.

Clinical Features : Paresthesias, numbness, and burning pain localized to the palmar aspect of the thumb, index, middle, and radial half of the ring finger; symptoms characteristically awaken the patient at night.

Physical Maneuvers : Durkan carpal compression test (most sensitive and specific; direct thumb pressure over carpal tunnel for 30 seconds reproduces symptoms); Phalen test (sustained wrist flexion at 90° for 60 seconds); Tinel sign (light tapping over volar wrist).

Management : First-line conservative management is a nocturnal wrist splint in neutral position (0° to 5° extension) . If refractory, local corticosteroid injection or surgical transverse carpal ligament release is indicated.

Lateral Epicondylitis ("Tennis Elbow") :

Mechanism : Repetitive wrist extension and forearm supination (e.g., carpentry, plumbing, computer mousing), resulting in microtears and angiofibroblastic tendinosis of the extensor carpi radialis brevis (ECRB) tendon origin at the lateral humeral epicondyle.

Physical Examination : Maximal point tenderness 1 to 2 cm distal to the lateral epicondyle; pain reproduced by resisted wrist extension with the elbow in full extension ( Cozen test ).

Medial Epicondylitis ("Golfer's Elbow") :

Mechanism : Repetitive wrist flexion and forearm pronation; tendinosis of the common flexor-pronator origin ( pronator teres and flexor carpi radialis ).

Physical Examination : Point tenderness over the medial epicondyle; pain reproduced by resisted wrist flexion and forearm pronation.

Ergonomic Workstation Optimization (The 90-90-90 Rule)

Seating Posture : The 90-90-90 rule mandates that elbows, hips, and knees should each maintain approximately a 90° angle during computer workstation tasks.

Monitor Alignment : The top edge of the computer screen should sit at or slightly below eye level at an arm's length distance (20 to 28 inches) to eliminate cervical hyperextension.

Wrist Alignment : Wrists must remain in a straight, neutral plane; avoid resting forearms or wrists against sharp desk edges.

Micro-Breaks : Implement the 20-20-20 rule (every 20 minutes, look at an object 20 feet away for 20 seconds) and short hourly postural stretch breaks.

Occupational Bloodborne Pathogen Exposure Protocol

Healthcare workers, emergency personnel, and laboratory staff face daily occupational risks of percutaneous injuries (needlesticks) and mucosal splashes involving bloodborne pathogens: Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV).

Transmission Risks Following Percutaneous Hollow-Bore Needlestick

Hepatitis B Virus (HBV) : ~30% transmission risk in an unvaccinated, non-immune individual if the source patient is Hepatitis B e-antigen positive (HBeAg-positive); drops to ~6% if HBeAg-negative.

Hepatitis C Virus (HCV) : ~1.8% (approximately 2 per 100 exposures).

Human Immunodeficiency Virus (HIV) : ~0.3% (approximately 3 per 1,000 percutaneous hollow-bore needle exposures); mucous membrane splash exposure risk is ~0.09% (less than 1 per 1,000).

Immediate Post-Exposure Management

Wound Care : Immediately wash the wound and puncture site with copious soap and water. Flush exposed mucous membranes or eyes with sterile saline or water for at least 15 minutes.

PROHIBITED ACTIONS : Do NOT squeeze, milk, or suck the wound (increases tissue trauma and viral inoculation); do NOT apply caustic antiseptics such as bleach, iodine, or alcohol into the wound.

Baseline Testing : Immediately draw blood from the exposed worker for: HIV antibody/antigen, anti-HBs (hepatitis B surface antibody), anti-HCV, and liver enzymes. Obtain consent and test the source patient for: HIV antibody/antigen, HBsAg, and HCV antibody.

Master Comparison: Bloodborne Pathogen Post-Exposure Prophylaxis (PEP)

Pathogen Indications & Prophylactic Regimen Optimal Timing & Duration Follow-up Testing Schedule

HIV Indicated for percutaneous or mucosal exposure to blood/body fluids from an HIV-positive source or unknown high-risk source. Regimen: 3-drug antiretroviral therapy :; • Tenofovir Disoproxil Fumarate (TDF 300 mg) + Emtricitabine (FTC 200 mg) once daily PLUS ; • Dolutegravir (DTG 50 mg) once daily (or Raltegravir [RAL 400 mg] BID) Initiate ASAP, ideally within 2 hours ; must be started within 72 hours (ineffective if initiated >72h); complete full 28-day course Baseline, 6 weeks , and 4 months post-exposure (or 6 months if 3rd-generation ELISA used) using 4th-generation HIV Ag/Ab immunoassay

Hepatitis B (HBV) Vaccinated with anti-HBs ≥10 mIU/mL : No PEP needed.; Unvaccinated or known non-responder : Administer Hepatitis B Immune Globulin (HBIG 0.06 mL/kg) intramuscularly AND initiate the 3-dose Hepatitis B vaccine series at separate anatomic injection sites Administer HBIG within 24 hours (ineffective if >7 days); administer vaccine within 24 hours Anti-HBs and HBsAg testing at 9 to 12 months (1–2 months after completing 3-dose vaccine series)

Hepatitis C (HCV) NO post-exposure prophylaxis or immune globulin exists for HCV; immunoglobulin and antivirals are not approved for post-exposure prophylaxis N/A Baseline anti-HCV and ALT; test HCV RNA at 3 to 6 weeks ; if HCV RNA positive, initiate curative direct-acting antivirals (DAAs)

Recreational Safety Counseling in Family Medicine
Traumatic Brain Injury (TBI) Prevention & Helmet Counseling

Epidemiology : Bicycling, skateboarding, roller sports, skiing, snowboarding, and all-terrain vehicles (ATVs) are major sources of pediatric and adult recreational traumatic brain injury.

Protective Efficacy : Proper, consistent bicycle helmet use reduces the risk of serious head injury and traumatic brain injury by 60% to 85% , and severe facial injury by 65%.

Standards and Fit : Helmets must carry Consumer Product Safety Commission (CPSC) certification. Clinicians should counsel the "Eyes, Ears, Mouth" fit check :

Eyes : Helmet rim should sit level across the forehead, no more than 1 to 2 finger-widths above the eyebrows.

Ears : Side straps should form a snug "V" shape directly beneath each earlobe.

Mouth : Chin strap should be buckled securely so that when the patient opens their mouth wide, the helmet pulls downward firmly on the crown.

Replacement Rule : Helmets must be replaced immediately after any significant impact crash (even if no external crack is visible, the internal expanded polystyrene foam compresses and permanently loses impact-absorption capacity) and routinely replaced every 3 to 5 years due to UV and adhesive degradation.

Water Safety and Drowning Prevention

Epidemiology : Drowning is the leading cause of unintentional injury death among children aged 1 to 4 years and the second leading cause in children aged 1 to 14 years.

Primary Preventive Interventions :

4-Sided Pool Isolation Fencing : The single most effective structural intervention, reducing pediatric residential pool drownings by >80% . Fencing must completely separate the swimming pool from the private residence and yard; must be at least 4 feet (1.2 meters) in height ; and must feature a self-closing, self-latching gate that opens outward away from the pool.

Constant "Touch Supervision" : An alert, sober adult must remain within arm's reach of infants and toddlers at all times when they are in, on, or near water (including bathtubs, wading pools, and spas).

Life Jackets : Children, non-swimmers, and all boaters must wear U.S. Coast Guard-approved life jackets (Personal Flotation Devices - PFDs) . Inflatable "water wings," inner tubes, and foam noodles are recreational toys, not life-saving safety devices.

Alcohol Avoidance : Alcohol is implicated in over 50% of adolescent and adult recreational drowning fatalities.

Ultraviolet (UV) Radiation Protection (USPSTF Grade B)

USPSTF Recommendation : Recommends counseling children, adolescents, and young adults aged 6 months to 24 years who have fair skin types regarding minimizing ultraviolet radiation exposure to reduce lifetime risks of cutaneous melanoma and keratinocyte carcinomas ( Grade B recommendation ).

Photoprotection Guidelines :

Sunscreen Application : Broad-spectrum (UVA and UVB protection) water-resistant sunscreen with a Sun Protection Factor ( SPF) ≥30 . Applied generously (approx. 1 ounce / 30 mL for full adult body) 15 to 30 minutes before sun exposure , and reapplied at least every 2 hours , or immediately after 40 to 80 minutes of swimming or heavy diaphoresis.

Sun Avoidance : Avoid outdoor exposure during peak UV irradiance hours between 10:00 AM and 4:00 PM .

Protective Apparel : Wide-brimmed hats (≥3-inch brim protecting face, ears, and neck), UV-blocking sunglasses (UV400 or 100% UVA/UVB protection), and tightly woven ultraviolet protection factor (UPF) clothing.

Infants Younger Than 6 Months : Must be kept out of direct sunlight entirely; shaded by strollers and umbrellas; dressed in lightweight long pants and brimmed hats. Sunscreen should be minimized on infants <6 months, applied only in small amounts to small exposed areas (face, dorsum of hands) if adequate shade and clothing are unavailable.

Prevention and Staging of Exertional Heat Illness

Exertional heat illness exists along a continuous clinical spectrum:

Condition Core Body Temperature Neurological Status & Mental State Physical Findings & Skin Condition Clinical Management & Triage

Heat Cramps Normal (37°C / 98.6°F) Normal mentation ; alert and oriented Painful, involuntary, spasmodic muscle contractions (calves, hamstrings, quadriceps, abdominals); profuse sweating Rest in cool shade; oral rehydration with electrolyte-rich fluids (salt-containing solutions; plain water alone worsens hyponatremic cramping); gentle passive stretching

Heat Exhaustion Elevated, but <40°C (<104°F) Normal mentation ; may have mild dizziness, lightheadedness, or headache; NO confusion or ataxia Heavy diaphoresis, pallor, tachycardia, orthostatic hypotension, nausea, vomiting, weakness Move to air-conditioned environment; remove restrictive clothing; elevate legs; oral or IV isotonic saline rehydration; active fan cooling; monitor core temperature

Heat Stroke (Medical Emergency) Severely elevated: ≥40°C (≥104°F) (measured via rectal probe) SEVERELY ALTERED MENTAL STATUS : Delirium, confusion, combativeness, ataxia, seizures, or coma Classic (Non-Exertional) : Elderly/debilitated; dry, hot, anhidrotic skin.; Exertional : Young athletes/workers; profuse diaphoresis is frequently present ; multiorgan failure (DIC, rhabdomyolysis) IMMEDIATE AGGRESSIVE COOLING : Cold-water / ice-water immersion is the gold standard; cool first, transport second; reduce core temp to 38.3°C–38.9°C (101°F–102°F) before stopping immersion to prevent hypothermic overshoot

Prevention in Outdoor Workers & Athletes :

Graduated Acclimatization : Progressive physical exertion in hot environments over 7 to 14 days to stimulate physiological adaptations (increased plasma volume, earlier onset of sweating with lower electrolyte concentration, enhanced cardiac output).

Hydration Protocols : Drink 8 ounces (240 mL) of cool water or electrolyte drink every 15 to 20 minutes during continuous exertion in the heat; do not rely on thirst alone.

Wet Bulb Globe Temperature (WBGT) : Monitor WBGT (which integrates ambient temperature, humidity, wind velocity, and solar radiant heat) to dictate mandatory work/rest cycles and exercise cancellations.